4AB:ETR
AbbVie Common Stock
260,80 €
arrow_upward
+0,42%(+1,10) 1D
9 ნოე, 17:35:37 GMT+1 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 4AB...
Open
262,80 €
High
264,50 €
Low
259,50 €
Mkt. cap
518,44 მლრ.
Avg. vol.
912,00
Volume
407,00
52-wk high
270,70 €
52-wk low
162,85 €
No. of employees
57 ათ.
Open
262,80 €
High
264,50 €
Low
259,50 €
Mkt. cap
518,44 მლრ.
Avg. vol.
912,00
Volume
407,00
52-wk high
270,70 €
52-wk low
162,85 €
No. of employees
57 ათ.
News stories
From web sources and news partners
The Globe and Mail
·
9 საათის წინ
Zacks Investment Ideas feature highlights: Moderna, AbbVie, Eli Lilly and Merck
Manufacturing Chemist
·
9 საათის წინ
AbbVie expands Oxford R&D facility in £120m UK life sciences investment
This Is Oxfordshire
·
16 საათის წინ
Pharmaceutical giant opens £120m research centre in Oxford
Profile
AbbVie Inc., also known as AbbVie, is an American pharmaceutical company headquartered in North Chicago, Illinois. AbbVie produces drugs to treat a wide range of medical issues.
The company is ranked sixth on the list of largest biomedical companies by revenue. It is ranked 77th on the Fortune 500 and 108th on the Forbes Global 2000. The name "AbbVie" is derived from a combination of "Abbott", the name of its former parent company, with "vie", intended as a reference to a Latin root meaning 'life'. Wikipedia
About AbbVie Common Stock
CEOრობერ ეი მაიკლ
Employees57 ათ.
Founded10 აპრ. 2012
HeadquartersNorth Chicago, ილინოისი, ამერიკის შეერთებული შტატები
SectorHealth Care
Industry-
Websiteabbvie.com